Final answer:
The mutant p53 gene most likely acts in a haploinsufficient manner, meaning that both copies of the gene need to be functional for its tumor-suppressor role to be effective.
Step-by-step explanation:
The most likely true statement in this scenario is that the p53 gene can act in a haploinsufficient manner.
Normally, one functional copy of the p53 gene is enough to prevent cancer. However, in this group of patients with multiple myeloma, having one normal p53 gene and one mutant p53 gene suggests that the mutant p53 gene alone is not sufficient to cause cancer. This indicates that the p53 gene can act in a haploinsufficient manner, meaning that both copies of the gene need to be functional for its tumor-suppressor role to be effective.
This finding is consistent with the recessive behavior typically observed in mutant forms of tumor-suppressor genes.